Times Square Capital Management, LLC Catalent, Inc. Transaction History

Times Square Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$72.36 - $113.1 $16.4 Million - $25.6 Million	-226,350 Reduced 17.49%	1,067,600 $77.3 Million
Q2 2022 Aug 05, 2022	BUY	$87.2 - $114.05 $65,400 - $85,537	750 Added 0.06%	1,293,950 $139 Million
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $17.7 Million - $23.3 Million	-187,400 Reduced 12.66%	1,293,200 $143 Million
Q4 2021 Feb 04, 2022	BUY	$119.57 - $139.07 $1.79 Million - $2.09 Million	15,000 Added 1.02%	1,480,600 $190 Million
Q3 2021 Nov 08, 2021	SELL	$109.17 - $142.35 $37.6 Million - $49 Million	-344,400 Reduced 19.03%	1,465,600 $195 Million
Q2 2021 Aug 09, 2021	BUY	$100.34 - $115.69 $20.9 Million - $24.1 Million	208,500 Added 13.02%	1,810,000 $196 Million
Q1 2021 May 12, 2021	BUY	$101.51 - $125.27 $28 Million - $34.6 Million	276,000 Added 20.82%	1,601,500 $169 Million
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $23.6 Million - $28.9 Million	274,650 Added 26.14%	1,325,500 $138 Million
Q3 2020 Nov 06, 2020	SELL	$72.74 - $92.5 $3.47 Million - $4.42 Million	-47,750 Reduced 4.35%	1,050,850 $90 Million
Q2 2020 Aug 07, 2020	SELL	$48.02 - $79.04 $20.7 Million - $34.1 Million	-430,975 Reduced 28.18%	1,098,600 $80.5 Million
Q1 2020 May 08, 2020	BUY	$36.95 - $62.95 $1.07 Million - $1.83 Million	29,015 Added 1.93%	1,529,575 $79.5 Million
Q4 2019 Feb 05, 2020	BUY	$47.06 - $56.64 $70.6 Million - $85 Million	1,500,560 New	1,500,560 $84.5 Million

216

73.2M

477K

2.02M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.